Skip to main content
← All trials
Sleep DisorderSupplementsNutrition and dietSleepCognitive functionBrain and nervesDietary supplement

What this study is

Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.

What's being tested

  • Branched Chain Amino Acids

    Intervention · DIETARY SUPPLEMENT

    60 grams of BCAA (2:1:1 ratio of Leucine:Isoleucine:Valine) consumed in two doses (30 grams each) mixed into 20 oz of water for up to21days (42 total drinks).

  • Rice Protein

    Intervention · DIETARY SUPPLEMENT

    60 grams of rice protein consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21days (42 total drinks).

  • Microcrystalline Cellulose

    Intervention · DIETARY SUPPLEMENT

    60 grams of microcrystalline cellulose, consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21days (42 total drinks).

Study details

Official title
A Pilot Study of Dietary Supplementation With Branched Chain Amino Acids on Sleep
Sponsor
Portland VA Medical Center
Conditions
Sleep Disorder · Traumatic Brain Injury
Enrolling
300 people
Starts
2019-03-01
Est. completion
2028-12-01
Design
Double-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗